BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 35042018)

  • 21. Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression.
    Lim CK; Bilgin A; Lovejoy DB; Tan V; Bustamante S; Taylor BV; Bessede A; Brew BJ; Guillemin GJ
    Sci Rep; 2017 Feb; 7():41473. PubMed ID: 28155867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis.
    Pieragostino D; D'Alessandro M; di Ioia M; Rossi C; Zucchelli M; Urbani A; Di Ilio C; Lugaresi A; Sacchetta P; Del Boccio P
    Mol Biosyst; 2015 Jun; 11(6):1563-72. PubMed ID: 25690641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolomics in rheumatoid arthritis: Advances and review.
    Xu L; Chang C; Jiang P; Wei K; Zhang R; Jin Y; Zhao J; Xu L; Shi Y; Guo S; He D
    Front Immunol; 2022; 13():961708. PubMed ID: 36032122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum metabolomics in animal models and human disease.
    James EL; Parkinson EK
    Curr Opin Clin Nutr Metab Care; 2015 Sep; 18(5):478-83. PubMed ID: 26147529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases.
    Cui L; Lu H; Lee YH
    Mass Spectrom Rev; 2018 Nov; 37(6):772-792. PubMed ID: 29486047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a Data-Independent Targeted Metabolomics Method for Relative Quantification Using Liquid Chromatography Coupled with Tandem Mass Spectrometry.
    Chen Y; Zhou Z; Yang W; Bi N; Xu J; He J; Zhang R; Wang L; Abliz Z
    Anal Chem; 2017 Jul; 89(13):6954-6962. PubMed ID: 28574715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolomics: Challenges and Opportunities in Systems Biology Studies.
    Mediani A; Baharum SN
    Methods Mol Biol; 2024; 2745():77-90. PubMed ID: 38060180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of Ion Chromatography Coupled with Mass Spectrometry for Human Serum and Urine Metabolomics.
    Sun Y; Saito K; Iiji R; Saito Y
    SLAS Discov; 2019 Aug; 24(7):778-786. PubMed ID: 31166806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonocclusive Sweat Collection Combined with Chemical Isotope Labeling LC-MS for Human Sweat Metabolomics and Mapping the Sweat Metabolomes at Different Skin Locations.
    Hooton K; Li L
    Anal Chem; 2017 Aug; 89(15):7847-7851. PubMed ID: 28679039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent advances in metabolomics in neurological disease, and future perspectives.
    Zhang AH; Sun H; Wang XJ
    Anal Bioanal Chem; 2013 Oct; 405(25):8143-50. PubMed ID: 23715678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolomics and health: from nutritional crops and plant-based pharmaceuticals to profiling of human biofluids.
    Marchev AS; Vasileva LV; Amirova KM; Savova MS; Balcheva-Sivenova ZP; Georgiev MI
    Cell Mol Life Sci; 2021 Oct; 78(19-20):6487-6503. PubMed ID: 34410445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are cerebrospinal fluid biomarkers useful in predicting the prognosis of multiple sclerosis patients?
    Gajofatto A; Bongianni M; Zanusso G; Benedetti MD; Monaco S
    Int J Mol Sci; 2011; 12(11):7960-70. PubMed ID: 22174643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomics and metabolomics analyses reveal the full spectrum of inflammatory and lipid metabolic abnormalities in dyslipidemia.
    Du H; Rao Y; Liu R; Deng K; Guan Y; Luo D; Mao Q; Yu J; Bo T; Fan Z; Ouyang H; Feng Y; Zhu W
    Biomed Chromatogr; 2021 Oct; 35(10):e5183. PubMed ID: 34058018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development.
    Ben-Nun A; Kaushansky N; Kawakami N; Krishnamoorthy G; Berer K; Liblau R; Hohlfeld R; Wekerle H
    J Autoimmun; 2014 Nov; 54():33-50. PubMed ID: 25175979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of metabolomics approaches and their application in identifying causal pathways of childhood asthma.
    Turi KN; Romick-Rosendale L; Ryckman KK; Hartert TV
    J Allergy Clin Immunol; 2018 Apr; 141(4):1191-1201. PubMed ID: 28479327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two untargeted metabolomics reveals yogurt-associated metabolic alterations in women with multiple metabolic disorders from a randomized controlled study.
    Du S; Chen Y; Liu X; Zhang Z; Jiang Y; Zhou Y; Zhang H; Li Q; XuemeiWang ; Wang Y; Feng R
    J Proteomics; 2022 Feb; 252():104394. PubMed ID: 34666202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small molecule metabolites: discovery of biomarkers and therapeutic targets.
    Qiu S; Cai Y; Yao H; Lin C; Xie Y; Tang S; Zhang A
    Signal Transduct Target Ther; 2023 Mar; 8(1):132. PubMed ID: 36941259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomic applications in nutritional research: a perspective.
    O'Gorman A; Brennan L
    J Sci Food Agric; 2015 Oct; 95(13):2567-70. PubMed ID: 25640072
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrated Lipidomics and Metabolomics Analysis of Tears in Multiple Sclerosis: An Insight into Diagnostic Potential of Lacrimal Fluid.
    Cicalini I; Rossi C; Pieragostino D; Agnifili L; Mastropasqua L; di Ioia M; De Luca G; Onofrj M; Federici L; Del Boccio P
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30871169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolomics as a Functional Tool in Screening Gastro Intestinal Diseases: Where are we in High Throughput Screening?
    Gundamaraju R; Vemuri R; Eri R; Ishiki HM; Coy-Barrera E; Yarla NS; Dos Santos SG; Alves MF; Barbosa Filho JM; Diniz MFFM; Scotti MT; Scotti L
    Comb Chem High Throughput Screen; 2017; 20(3):247-254. PubMed ID: 28000563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.